Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.88B |
| 2 |
AGN
Allergan plc
AGN
|
+$565M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$527M |
| 4 |
Fiserv
FI
|
+$518M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$471M |
Top Sells
| 1 |
APC
Anadarko Petroleum
APC
|
+$688M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$427M |
| 3 |
Blackstone
BX
|
+$417M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$391M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$338M |
Sector Composition
| 1 | Technology | 15.1% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.85% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Industrials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Star Group
SGU
$394M
| $148K | ﹤0.01% |
15,628
-2,789
| -15% | -$26.4K |
|
3927
Ocular Therapeutix
OCUL
$2.22B
| $147K | ﹤0.01% |
48,286
+14,265
| +42% | +$43.4K |
|
3928
Spero Therapeutics
SPRO
$111M
| $146K | ﹤0.01% |
13,806
-8,171
| -37% | -$86.4K |
|
3929
Kezar Life Sciences
KZR
$29.4M
| $143K | ﹤0.01% |
4,367
+2,910
| +200% | +$95.3K |
|
|
UXIN
3930
Uxin Ltd
UXIN
$693M
| $143K | ﹤0.01% |
+582
| New | +$143K |
|
3931
NCS Multistage Holdings
NCSM
$115M
| $139K | ﹤0.01% |
3,465
-509
| -13% | -$20.4K |
|
|
OTIC
3932
DELISTED
Otonomy, Inc.
OTIC
| $138K | ﹤0.01% |
57,860
-7,716
| -12% | -$18.4K |
|
3933
AC Immune
ACIU
$221M
| $137K | ﹤0.01% |
27,606
+4,291
| +18% | +$21.3K |
|
3934
Crawford & Co Class B
CRD.B
$509M
| $135K | ﹤0.01% |
13,423
-83,078
| -86% | -$836K |
|
3935
Genie Energy
GNE
$396M
| $135K | ﹤0.01% |
18,050
+7,995
| +80% | +$59.8K |
|
|
DZSI
3936
DELISTED
DZS Inc. Common Stock
DZSI
| $135K | ﹤0.01% |
+14,705
| New | +$135K |
|
3937
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.6B
| $134K | ﹤0.01% |
14,645
| – | – |
|
3938
Ranpak Holdings
PACK
$408M
| $134K | ﹤0.01% |
22,141
+8,914
| +67% | +$53.9K |
|
3939
J. Jill
JILL
$276M
| $133K | ﹤0.01% |
14,003
-12,733
| -48% | -$121K |
|
3940
First Trust Energy AlphaDEX Fund
FXN
$282M
| $131K | ﹤0.01% |
+13,321
| New | +$131K |
|
|
ENZ
3941
DELISTED
Enzo Biochem, Inc.
ENZ
| $131K | ﹤0.01% |
36,403
-83,923
| -70% | -$302K |
|
|
MRNS
3942
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $130K | ﹤0.01% |
20,982
-437,125
| -95% | -$2.71M |
|
|
DOYU
3943
DouYu International Holdings
DOYU
$242M
| $129K | ﹤0.01% |
+1,580
| New | +$129K |
|
|
VTIQW
3944
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
| $128K | ﹤0.01% |
180,000
| – | – |
|
3945
Perion Network
PERI
$409M
| $127K | ﹤0.01% |
+25,875
| New | +$127K |
|
|
DBVT
3946
DBV Technologies
DBVT
$238M
| $125K | ﹤0.01% |
1,449
+233
| +19% | +$20.1K |
|
|
TREC
3947
DELISTED
Trecora Resources
TREC
| $125K | ﹤0.01% |
+13,814
| New | +$125K |
|
|
NWHM
3948
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $125K | ﹤0.01% |
28,724
-37,352
| -57% | -$163K |
|
3949
Neuronetics
STIM
$244M
| $121K | ﹤0.01% |
+14,503
| New | +$121K |
|
|
IO
3950
DELISTED
ION Geophysical Corporation
IO
| $120K | ﹤0.01% |
13,128
-18,259
| -58% | -$167K |
|